Royalty Pharma plc Quarterly General and Administrative Expense in USD from Q2 2019 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Royalty Pharma plc quarterly/annual General and Administrative Expense history and growth rate from Q2 2019 to Q2 2025.
- Royalty Pharma plc General and Administrative Expense for the quarter ending June 30, 2025 was $180M, a 229% increase year-over-year.
- Royalty Pharma plc General and Administrative Expense for the twelve months ending June 30, 2025 was $415M, a 81.3% increase year-over-year.
- Royalty Pharma plc annual General and Administrative Expense for 2024 was $237M, a 5.24% decline from 2023.
- Royalty Pharma plc annual General and Administrative Expense for 2023 was $250M, a 9.87% increase from 2022.
- Royalty Pharma plc annual General and Administrative Expense for 2022 was $227M, a 24.3% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)